Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ocular Therapeutix (OCUL) Other Non-Current Assets (2016 - 2025)

Ocular Therapeutix has reported Other Non-Current Assets over the past 13 years, most recently at $1.6 million for Q4 2025.

  • Quarterly results put Other Non-Current Assets at $1.6 million for Q4 2025, changed 0.0% from a year ago — trailing twelve months through Dec 2025 was $1.6 million (changed 0.0% YoY), and the annual figure for FY2025 was $1.6 million, changed 0.0%.
  • Other Non-Current Assets for Q4 2025 was $1.6 million at Ocular Therapeutix, roughly flat from $1.6 million in the prior quarter.
  • Over the last five years, Other Non-Current Assets for OCUL hit a ceiling of $1.8 million in Q1 2021 and a floor of $1.6 million in Q4 2023.
  • Median Other Non-Current Assets over the past 5 years was $1.8 million (2021), compared with a mean of $1.7 million.
  • Biggest five-year swings in Other Non-Current Assets: changed 0.0% in 2021 and later dropped 8.5% in 2023.
  • Ocular Therapeutix's Other Non-Current Assets stood at $1.8 million in 2021, then changed by 0.0% to $1.8 million in 2022, then dropped by 8.5% to $1.6 million in 2023, then changed by 0.0% to $1.6 million in 2024, then changed by 0.0% to $1.6 million in 2025.
  • The last three reported values for Other Non-Current Assets were $1.6 million (Q4 2025), $1.6 million (Q3 2025), and $1.6 million (Q2 2025) per Business Quant data.